READ-ONLY DIGITIZATION RESULT
Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K-Mutant Advanced or Metastatic Melanoma.
Clin Cancer Res · 2026-Apr-01 · PMID 41537702
Panel C质量警告待 EXE 对齐验证
PFS
Figure 1. PFS and OS for encorafenib plus binimetinib or encorafenib vs. vemurafenib by ( A and B ) TMB and ( C and D ) cytolytic score. E, Volcano plots of univariable gene expression associations with OS in each arm based on z -scored gene expression values. F, Gene-set enrichment analysis of gene expression associations against hallmark gene signatures; signatures with greatest average NES across arms shown. Bini, binimetinib; BM, biomarker; CYT, cytotoxic score; Enco, encorafenib; NES, normalized enrichment scores; Vemu, vemurafenib.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
| Curve | 序号 | X (norm) | Y (norm) | X (real) | Y (real) | X (pixel) | Y (pixel) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 0.0000 | 0.3089 | 1.3832 | 12 | 174 | |
| 1 | 2 | 0.2206 | 0.3089 | 1.3832 | 179 | 174 | |
| 1 | 3 | 0.2219 | 0.3089 | 1.3832 | 180 | 174 | |
| 1 | 4 | 0.2232 | 0.3089 | 1.3832 | 181 | 174 | |
| 1 | 5 | 0.2246 | 0.3089 | 1.3832 | 182 | 174 | |
| 1 | 6 | 0.2259 | 0.3089 | 1.3832 | 183 | 174 | |
| 1 | 7 | 0.2272 | 0.3049 | 1.3645 | 184 | 175 | |
| 1 | 8 | 0.2285 | 0.3049 | 1.3645 | 185 | 175 | |
| 1 | 9 | 0.2299 | 0.3049 | 1.3645 | 186 | 175 | |
| 1 | 10 | 0.2312 | 0.3049 | 1.3645 | 187 | 175 | |
| 1 | 11 | 0.2325 | 0.3049 | 1.3645 | 188 | 175 | |
| 1 | 12 | 0.2338 | 0.3049 | 1.3645 | 189 | 175 | |
| 1 | 13 | 0.2351 | 0.3049 | 1.3645 | 190 | 175 | |
| 1 | 14 | 0.2365 | 0.3049 | 1.3645 | 191 | 175 | |
| 1 | 15 | 0.2378 | 0.3049 | 1.3645 | 192 | 175 | |
| 1 | 16 | 0.2391 | 0.3049 | 1.3645 | 193 | 175 | |
| 1 | 17 | 0.2404 | 0.3049 | 1.3645 | 194 | 175 | |
| 1 | 18 | 0.2417 | 0.3171 | 1.4206 | 195 | 172 | |
| 1 | 19 | 0.2431 | 0.3211 | 1.4393 | 196 | 171 | |
| 1 | 20 | 0.2444 | 0.3211 | 1.4393 | 197 | 171 | |
| 1 | 21 | 0.2457 | 0.3333 | 1.4953 | 198 | 168 | |
| 1 | 22 | 0.2470 | 0.3415 | 1.5327 | 199 | 166 | |
| 1 | 23 | 0.2483 | 0.3415 | 1.5327 | 200 | 166 | |
| 1 | 24 | 0.2497 | 0.3455 | 1.5514 | 201 | 165 | |
| 1 | 25 | 0.2510 | 0.3008 | 1.3458 | 202 | 176 | |
| 1 | 26 | 0.2523 | 0.2967 | 1.3271 | 203 | 177 | |
| 1 | 27 | 0.2536 | 0.2967 | 1.3271 | 204 | 177 | |
| 1 | 28 | 0.2550 | 0.2967 | 1.3271 | 205 | 177 | |
| 1 | 29 | 0.2563 | 0.2967 | 1.3271 | 206 | 177 | |
| 1 | 30 | 0.2576 | 0.2967 | 1.3271 | 207 | 177 | |
| 1 | 31 | 0.2589 | 0.2967 | 1.3271 | 208 | 177 | |
| 1 | 32 | 0.2602 | 0.2967 | 1.3271 | 209 | 177 | |
| 1 | 33 | 0.2616 | 0.2967 | 1.3271 | 210 | 177 | |
| 1 | 34 | 0.2629 | 0.2967 | 1.3271 | 211 | 177 |
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | quality_warning | 待验证 | 4 | 2026-07-23T16:56:23+00:00 |